<DOC>
	<DOCNO>NCT01259791</DOCNO>
	<brief_summary>This study consist series prospective , randomized placebo-controlled n 1 trial objectively evaluate reproducibility subjective objective symptom among patient history statin-related myopathy .</brief_summary>
	<brief_title>Evaluation Patients With Statin Myopathy Using N 1 Trial Design</brief_title>
	<detailed_description />
	<mesh_term>Muscular Diseases</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>history muscle symptom occur within 3 week start statin need statin therapy achieve LDL target accord 2009 Canadian Lipid Guidelines willingness retry statin therapy currently tolerant statin therapy metabolic inflammatory myopathy know neuropathy CK elevation &gt; 3 time upper limit normal ( ULN ) previously statin history rhabdomyolysis pregnant , breastfeeding , want become pregnant near future participation another clinical trial medical condition associate decreased life span inability adhere stringent regimen unwilling stop consumption grapefruit juice Subset 5 patient also complete neuromuscular testing : also : angina III IV decompensated heart failure history orthopedic problem skin ulcer nonhealed skin area infection arm leg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>